John C.k. Milligan IV, President at TherapeuticsMD, Inc. (TXMD), sold 25,000 shares at $6.16 ($158K) on 2014-02-25, disclosed to the SEC on 2014-02-26.
Scheduled sale ($158k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.23 | 8,300 | $52K | 32.8% |
| 2 | $6.16 | 8,300 | $51K | 32.4% |
| 3 | $6.53 | 8,400 | $55K | 34.8% |
| Total | $6.31 avg | 25,000 | $158K | 100% |
| Filing → |
| TXMD | BUY | 2019-08-19 | $29K | — | Filing → |
| TXMD | BUY | 2019-08-14 | $47K | — | Filing → |
| TXMD | SELL | 2018-12-19 | $1.4M | — | Filing → |